@article{471fbe294bc441c2a3da2a342dd03371,
title = "KeyVibe-003: Randomized, double-blind, phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1-positive metastatic NSCLC",
author = "Cho, \{Byoung Chul\} and Juergens, \{Rosalyn A.\} and Ying Cheng and \{de Castro\}, Gilberto and Mustafa Erman and Bauman, \{Jessica R.\} and Toshiaki Takahashi and Paul Schwarzenberger and Chengxiang Li and Pietanza, \{M. Catherine\} and Yang, \{James Chih-Hsin\}",
year = "2022",
month = jun,
day = "15",
language = "English",
volume = "82",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "12",
note = "Annual Meeting of the American-Association-for-Cancer-Research (AACR) ; Conference date: 08-04-2022 Through 13-04-2022",
}